182 related articles for article (PubMed ID: 32446902)
1. Immunoinformatic analysis of the SARS-CoV-2 envelope protein as a strategy to assess cross-protection against COVID-19.
Tilocca B; Soggiu A; Sanguinetti M; Babini G; De Maio F; Britti D; Zecconi A; Bonizzi L; Urbani A; Roncada P
Microbes Infect; 2020; 22(4-5):182-187. PubMed ID: 32446902
[TBL] [Abstract][Full Text] [Related]
2. Comparative computational analysis of SARS-CoV-2 nucleocapsid protein epitopes in taxonomically related coronaviruses.
Tilocca B; Soggiu A; Sanguinetti M; Musella V; Britti D; Bonizzi L; Urbani A; Roncada P
Microbes Infect; 2020; 22(4-5):188-194. PubMed ID: 32302675
[TBL] [Abstract][Full Text] [Related]
3. Bioinformatics analysis of epitope-based vaccine design against the novel SARS-CoV-2.
Chen HZ; Tang LL; Yu XL; Zhou J; Chang YF; Wu X
Infect Dis Poverty; 2020 Jul; 9(1):88. PubMed ID: 32741372
[TBL] [Abstract][Full Text] [Related]
4. Sars-CoV-2 Envelope and Membrane Proteins: Structural Differences Linked to Virus Characteristics?
Bianchi M; Benvenuto D; Giovanetti M; Angeletti S; Ciccozzi M; Pascarella S
Biomed Res Int; 2020; 2020():4389089. PubMed ID: 32596311
[TBL] [Abstract][Full Text] [Related]
5. Prediction and evolution of B cell epitopes of surface protein in SARS-CoV-2.
Lon JR; Bai Y; Zhong B; Cai F; Du H
Virol J; 2020 Oct; 17(1):165. PubMed ID: 33121513
[TBL] [Abstract][Full Text] [Related]
6. Identification of Novel Candidate Epitopes on SARS-CoV-2 Proteins for South America: A Review of HLA Frequencies by Country.
Requena D; Médico A; Chacón RD; Ramírez M; Marín-Sánchez O
Front Immunol; 2020; 11():2008. PubMed ID: 33013857
[TBL] [Abstract][Full Text] [Related]
7. Immunoinformatics-guided designing of epitope-based subunit vaccines against the SARS Coronavirus-2 (SARS-CoV-2).
Sarkar B; Ullah MA; Johora FT; Taniya MA; Araf Y
Immunobiology; 2020 May; 225(3):151955. PubMed ID: 32517882
[TBL] [Abstract][Full Text] [Related]
8. Strong homology between SARS-CoV-2 envelope protein and a Mycobacterium sp. antigen allows rapid diagnosis of Mycobacterial infections and may provide specific anti-SARS-CoV-2 immunity via the BCG vaccine.
Nuovo G; Tili E; Suster D; Matys E; Hupp L; Magro C
Ann Diagn Pathol; 2020 Oct; 48():151600. PubMed ID: 32805515
[TBL] [Abstract][Full Text] [Related]
9. Energetics and IC50 based epitope screening in SARS CoV-2 (COVID 19) spike protein by immunoinformatic analysis implicating for a suitable vaccine development.
Banerjee A; Santra D; Maiti S
J Transl Med; 2020 Jul; 18(1):281. PubMed ID: 32650788
[TBL] [Abstract][Full Text] [Related]
10. Ancestral origin, antigenic resemblance and epidemiological insights of novel coronavirus (SARS-CoV-2): Global burden and Bangladesh perspective.
Uddin MB; Hasan M; Harun-Al-Rashid A; Ahsan MI; Imran MAS; Ahmed SSU
Infect Genet Evol; 2020 Oct; 84():104440. PubMed ID: 32622082
[TBL] [Abstract][Full Text] [Related]
11. Identification of potential inhibitors against SARS-CoV-2 by targeting proteins responsible for envelope formation and virion assembly using docking based virtual screening, and pharmacokinetics approaches.
Bhowmik D; Nandi R; Jagadeesan R; Kumar N; Prakash A; Kumar D
Infect Genet Evol; 2020 Oct; 84():104451. PubMed ID: 32640381
[TBL] [Abstract][Full Text] [Related]
12. Molecular basis of COVID-19 relationships in different species: a one health perspective.
Tilocca B; Soggiu A; Musella V; Britti D; Sanguinetti M; Urbani A; Roncada P
Microbes Infect; 2020; 22(4-5):218-220. PubMed ID: 32194253
[TBL] [Abstract][Full Text] [Related]
13. Immunoinformatic identification of B cell and T cell epitopes in the SARS-CoV-2 proteome.
Crooke SN; Ovsyannikova IG; Kennedy RB; Poland GA
Sci Rep; 2020 Aug; 10(1):14179. PubMed ID: 32843695
[TBL] [Abstract][Full Text] [Related]
14. SARS-CoV-2 envelope protein topology in eukaryotic membranes.
Duart G; García-Murria MJ; Grau B; Acosta-Cáceres JM; Martínez-Gil L; Mingarro I
Open Biol; 2020 Sep; 10(9):200209. PubMed ID: 32898469
[TBL] [Abstract][Full Text] [Related]
15. Design of a multi-epitope vaccine against SARS-CoV-2 using immunoinformatics approach.
Sanami S; Zandi M; Pourhossein B; Mobini GR; Safaei M; Abed A; Arvejeh PM; Chermahini FA; Alizadeh M
Int J Biol Macromol; 2020 Dec; 164():871-883. PubMed ID: 32682041
[TBL] [Abstract][Full Text] [Related]
16. Immune and bioinformatics identification of T cell and B cell epitopes in the protein structure of SARS-CoV-2: A systematic review.
Noorimotlagh Z; Karami C; Mirzaee SA; Kaffashian M; Mami S; Azizi M
Int Immunopharmacol; 2020 Sep; 86():106738. PubMed ID: 32683296
[TBL] [Abstract][Full Text] [Related]
17. Structural insight into the role of novel SARS-CoV-2 E protein: A potential target for vaccine development and other therapeutic strategies.
Sarkar M; Saha S
PLoS One; 2020; 15(8):e0237300. PubMed ID: 32785274
[TBL] [Abstract][Full Text] [Related]
18. SARS-CoV-2 strategically mimics proteolytic activation of human ENaC.
Anand P; Puranik A; Aravamudan M; Venkatakrishnan AJ; Soundararajan V
Elife; 2020 May; 9():. PubMed ID: 32452762
[TBL] [Abstract][Full Text] [Related]
19. Immunoinformatics-guided design of an epitope-based vaccine against severe acute respiratory syndrome coronavirus 2 spike glycoprotein.
Rakib A; Sami SA; Mimi NJ; Chowdhury MM; Eva TA; Nainu F; Paul A; Shahriar A; Tareq AM; Emon NU; Chakraborty S; Shil S; Mily SJ; Ben Hadda T; Almalki FA; Emran TB
Comput Biol Med; 2020 Sep; 124():103967. PubMed ID: 32828069
[TBL] [Abstract][Full Text] [Related]
20. Epitope-based peptide vaccines predicted against novel coronavirus disease caused by SARS-CoV-2.
Lin L; Ting S; Yufei H; Wendong L; Yubo F; Jing Z
Virus Res; 2020 Oct; 288():198082. PubMed ID: 32621841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]